▶ Full Post Text
Alright, buckle up because this one meanders. Yesterday (3.11.26) Iran's Handala hacker group used a Microsoft exploit to remote wipe about 200,000 devices across Stryker's network. That data's gone, and reliant on backups. Who's Stryker? SYK is a major manufacturer of medical devices. Surgical robots, implants, you name it. They filed an 8k today stating that "the timeline for a full restoration is not yet known" and that their electronic ordering system is completely down, unable to accept new orders for equipemnt or implants. Their share price has dropped a tiny bit.
Why should you care? Because Stryker is currently unable to supply new orders for equipment, or for implants, which are ordered by surgical centers on a just-in-time basis. Remember that for the next five minutes, because it's important.
The ticker to watch: Surgery Partners. Surgery Partners ($SGRY) operates ~200 ambulatory surgery centers and surgical hospitals across 33 states. It's been slowly shitting itself to death in a world of ticketer margins and strong headwinds. Their fastest-growing and highest-revenue specialtry is orthopedics. Orthopedics and pain management make up ~40% of SGRY's total case mix. Joint replacements grew 19% yoy in 2025. In Q4 alone they did over 88,000 musculoskeletal procedures. They deployed 69 surgical robots and recruited 300 new physicians last year, with a heavy tilt toward ortho.
Now guess who makes the equipment they use for orthopedics? The power tools, the Mako robots, the visualization platforms, the implants themselves?
Yup, Stryker.
If they can't order new Stryker implants and they don't happen to have the exact knee they need for their surgery tomorrow on the shelf in the back room (and they don't), then they have to get postponed. Postponed procedures are lost revenue.
Here's why that's such a problem: - Q4 Earnings (March 2) reported a big miss - Margins keep compressing - Payer mix is deteriorating ( commercial payers are down to 50.6% of revenue, down 160bps YoY - Insider Selling (CFO, CEO, CHRO all sold on MArch 6 - Downgrades across the board. Analysts hate this.
And the move that tells me company leadership frequents this sub: They turned down a $25.75/share buyout from Bain Capital in January 2025. The board said "We're worth way more than that" and proceeded to drive the price below $13/share, and that was when they could still get implants when they wanted them.
"But won'tthis be resolved in a day or two?", I hear you asking. Of course it fucking won't. Let's compare this to two similar attacks in the past: Saudi Aramco in 2012 and Maersk in 2017. 30,000 devices were wiped for Saudi and it took weeks to restore. 45,000 PCs and 4,000 servers for Maersk took nearly two months. Remember, Stryker just lost 200,000 machines. That's four Maersks. This won't be resolved quickly, and that's time that SGRY can't afford.
The Play: June expiry puts and put spreads, or short call spreads in the high teens.
TL;DR: Iran-backed hackers wiped 200,000 Stryker devices yesterday. Stryker makes the equipment that Surgery Partners ($SGRY) uses to do ~41% of its surgeries. SGRY is leveraged to the tits, trading at 52-week lows, insiders just dumped shares, and the board rejected a $25.75 buyout when the stock was at $21. It's now $13. The Stryker disruption hasn't been priced into SGRY at all. Put spreads, June expiry.